跳至主要内容
临床试验/NCT07601464
NCT07601464招募中不适用

Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal Ablation

IRCCS Azienda Ospedaliero-Universitaria di Bologna1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年3月26日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1

研究概览

简要总结

The main objectives of this research project concern the identification of microRNAs circulating and of serum metabolites predictive of treatment response in patients with early stage hepatocellular carcinoma undergoing locoregional treatment with thermoablation.

In addition, the molecular mechanisms involved in reprogramming will be identified metabolic via bioinformatics analysis and pretreatment liver biopsy analysis and analysis of screening on patient-derived primary lines for personalized therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of hepatocarcinoma confirmed by radiology (LIRADS criteria/triphasic diagnostics) or by biopsy.
  • Indication for thermoablation treatment (for radiofrequency) based on the judgment of the hepatologist/surgeon.
  • Informed consent signed by the patient.

排除标准

  • Presence of metastatic liver lesions of other origins.
  • History of liver transplant.
  • Severe, uncorrectable coagulopathy, contraindicating liver biopsy (where necessary) or ablative procedure.
  • Patient refusal to participate in the study or inability to obtain informed consent.
  • Pregnant women.

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验